Partners to Collaborate on the Innovative
Production of Cannabidiol (CBD) Infused Cosmetic Products
TSX: ACB
EDMONTON, July 11, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today
that it has established a partnership agreement ("the Agreement")
with Evio Beauty Group Ltd. ("Evio Beauty") pursuant to which
Aurora has made a strategic investment in Evio Beauty. Under the
terms of the Agreement, Aurora and Evio Beauty Group will
collaborate to develop a line of co-branded hemp seed oil cosmetic
products ("Non-Infused Products") as well as a collection of CBD
infused cosmetic products ("Infused Products").
Evio Beauty is a portfolio of conscious lifestyle brands. The
well-developed cosmetic sister brand, Evelyn Iona, has a strong e-commerce presence
based on inclusivity, empowerment and choice, aimed at people of
all demographics. Evelyn Iona
products are based on sustainability principles. They are made with
natural ingredients and are always cruelty-free.
The partnership between Evio Beauty and Aurora is aimed at
creating a new line of approved hemp seed oil based product
formulations, as well as approved CBD based products. Aurora and
Evio Beauty anticipate that the partnership will result in greater
brand recognition and cross-selling opportunities to customers of
both companies.
The concept for Evio Beauty Group was developed by founder
Brandi Leifso who, while living in a
women's shelter, identified a need for lifestyle products that
offered stakeholders a greater opportunity to engage. Evio Beauty
Group's brand personifies quality, sustainability, equality, and
community engagement, as manifested through the company's events,
sponsorships, educational activities and outreach initiatives. A
respected entrepreneur within lifestyle and social engagement
circles, Brandi Leifso is a
sought-after spokesperson for events that align with the company's
motto of empowerment. This broad recognition and high visibility
have resulted in Evio Beauty successfully establishing
relationships with over 50 coveted retailers.
Evio Beauty is supported by a strong board of directors
including Paul Rosen, Managing
Partner of BreakWater Venture Capital, Hugh
Winters, President of Azure Beauty Inc and David Price, Vice President of sales for Hunter
Amenities International.
Management Commentary
"Through this partnership with Evio, Aurora further diversifies
its rapidly growing offering across the cannabis value chain, while
capturing a unique opportunity to bring the Aurora Standard to
cannabis derived lifestyle and cosmetic products," said
Terry Booth, CEO. "Innovative,
pioneering, noble entrepreneurs like Brandi closely align with
Aurora's internal culture, strengthening our spirit of diversity
and furthering our female empowerment initiatives. My personal
efforts have for many years supported the effort to end family
violence, and have been aimed at helping society understand that we
must support female empowerment. Aurora's culture, since the first
seed sown, has been one of fairness, inclusion and equality. This
has resulted in positions being awarded based on merit, regardless
of gender, race or religion. There is no alternative. We're excited
to work with Brandi and the team at Evio Beauty to develop and
launch this innovative new line of hemp seed and CBD-based cosmetic
products to a large and growing audience worldwide."
Brandi Leifso, CEO of Evio
Beauty, added, "The cannabis industry is uniquely positioned to
champion more women in leadership roles. With the strong support of
a dedicated partner like Aurora, we will continue to scale our
female empowerment initiatives while addressing pain points in the
cosmetics industry. By utilizing hemp seed oil and cannabis
derivatives, we can enhance ingredient transparency, reducing the
use of hurtful animal by-products and ecologically unsustainable
inputs."
About Aurora
Headquartered in Edmonton,
Alberta, with funded capacity in excess of 430,000 kg per
year and sales and operations in 14 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution. Aurora, from day one of its existence, has
been steadfast in its respect for the cannabis community, the
culture and its pioneers, as well as has been a strong supporter of
and advocate for access to cannabis.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes. Intended to be replicable and
scalable globally, these production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and ultra-low per gram production costs.
Each of Aurora's facilities is built to meet European Union (EU)
GMP standards, and both its first production facility and its
wholly owned European medical cannabis distributor Pedanios have
achieved this level of certification.
In addition to our rapid organic growth to over 1000 employees
world-wide, and strong execution on strategic M&A, which to
date includes nine companies acquired - CanvasRX, Peloton
Pharmaceutical, Pedanios, H2 Biopharma, Urban Cultivator, BC
Northern Lights, Larssen, CanniMed Therapeutics, and Anandia Labs -
Aurora is distinguished by its reputation as a partner of choice
and employer of choice in the global cannabis sector, having
invested in and established strategic partnerships with a range of
leading innovators, including: The Green Organic Dutchman Holdings
Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco
Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN),
Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc.
(CSE: CHOO), Namaste Technologies Inc. (TSXV: N), and Alcanna Inc.
(TSX: CLIQ).
Aurora's Common Shares trade on the TSX under the symbol "ACB",
and are a constituent of the S&P/TSX Composite Index.
For detailed investor information about Aurora, please visit our
investor website investor.auroramj.com.
About Evio Beauty Group
Evio Beauty Group Ltd. is a portfolio of conscious lifestyle
brands. Evio Beauty Group was created with a vision for a conscious
future and a mission to break stigmas with products that are good
for your skin, your planet and your community. Amongst the
growing Evio Beauty Group portfolio is Evelyn Iona
Cosmetics (www.evelyniona.com), a line of natural products that
fill the gap of hard-to-find cosmetics. Evelyn Iona has earned recognition from Vogue,
The New York Times, Elle, Flare,
Chatelaine and Allure for its unique founding story and high
performing products. Additionally, The Evio Beauty Group
portfolio is home to Evio Community
(www.eviocommunity.com), an online platform of curated content
stimulating conversation and collecting data on beauty, cannabis,
fashion, feminism, wellness and entrepreneurship. Most
recently, Evio Beauty Group announced its subsidiary
housing all Evio Beauty Group cannabis activity, Iona
Cannabis Corp.
Social impact is at the core of why Evio Beauty Group
exists. Evio Beauty Group is formally partnered with the Canadian
Women's Foundation through awareness activities and by donating
$1 from every product sold
at www.evelyniona.com to advance equality efforts.
Evio Beauty Group is a proud alumni of the esteemed Sephora's
Accelerate program. Sephora is a leader in global prestige retail.
Owned by LVMH (Moët Hennessy Louis
Vuitton), Sephora has earned its reputation as a beauty
trailblazer with its expertise, innovation, and entrepreneurial
spirit.
Forward looking statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur and include, but are not limited to a) the
success of the collaboration between the Company and Evio and b)
the development of the Infused Products and Non Infused Products
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Terry Booth, CEO
Aurora Cannabis Inc.
SOURCE Aurora Cannabis Inc.